First, Tromjaro boots very fast. On top of that, Tromjaro performs like a champ. This Linux distribution can compete with any lightweight OS on the market.
Multi-Static Active Coherent sonobuoys allow the MQ-9B to better detect submarines over large areas with fewer buoys than DIFAR and DICASS. General ...
System enhancement apps like Supercharge, Daisy Disk, and Dock Door allow users to customize macOS, optimize storage, and ...
Verywell Health on MSN
Types of complement 3 glomerulopathy: How they differ and what that means
Medically reviewed by Erika Prouty, PharmD Key Takeaways There are two types of complement 3 glomerulopathy: dense deposit ...
ESET Cyber Security for Mac provides reliable antivirus protection, advanced tools, and a strong lab score at a competitive ...
Bond yields look like to rise this year, despite the possibility of at least two Federal Reserve rate cuts. Even a small ...
In 2019 I wrote about research suggesting anti-inflammatory medications might help some people with major depression. At the time, the idea that depression could have roots in the immune system felt ...
The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...
Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...
A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, scientists preserved cognition in mice without dulling the cancer-killing ...
Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...
Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called "C3G" and prevent the disease progressing. Publishing in The Lancet, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results